Cases & Deals

  • Home
  • Practices
  • Bayer acquires consumer care business of U.S.-based Merck for $14.2 billion

Share

Bayer acquires consumer care business of U.S.-based Merck for $14.2 billion

October 2014

Client(s) Bayer AG

Jones Day advised Bayer AG on the antitrust aspects of its $14.2 billion acquisition of the consumer care business of U.S. pharmaceutical company Merck & Co., Inc. Merck's over-the-counter products include many in the cold, allergy, sinus & flu, dermatology (including sun care), foot health, and gastrointestinal categories, and leading brands such as Claritin™, Coppertone™, and Dr. Scholl’s™. The transaction closed on October 1, 2014, following receipt of required antitrust approvals.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.